Philadelphia, PA - Wyeth-Ayerst Pharmaceuticals have issued a letter alerting healthcare professionals to two dangers of Cordarone IV® (amiodarone HCL) use in pediatric patients, and detailing related ...

HealthDay News — In a report published online July 16 in the Journal of Clinical Pharmacy and Therapeutics, a case of survival after acute liver failure secondary to amiodarone administration is ...

Inadvertent administration may result in serious adverse events. Mylan announced the voluntary recall to the hospital/clinic level of 4 lots of Amiodarone HCl Injection, USP 450mg/9mL and Tranexamic ...

KING OF PRUSSIA, Pa., Jan. 5 /PRNewswire/ -- Prism Pharmaceuticals announced today that the U.S. Food & Drug Administration (FDA) has approved the new drug application (NDA) for NEXTERONE(R) ...

November 17, 2006 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to advise on the use of carvedilol tablets in diabetic patients; the risk for potentially fatal ...

Amiodarone was discovered in 1961, but was not approved by the FDA until 1985. Although classified as a class III antiarrhythmic, amiodarone exhibits properties of class I, II and IV antiarrhythmics ...

Amiodarone is a class III antiarrhythmic drug, with some class IA properties. Amiodarone on rare occasions can induce torsades de pointes within the first 48 hours of intravenous administration, even ...

SCHAUMBURG, Ill., July 25 Sagent Pharmaceuticals, Inc., aprivately-held specialty pharmaceutical company, today announced that it haslaunched amiodarone HCl injection, USP, a class III antiarrhythmic ...

What is amiodarone used for? Amiodarone is commonly used to prevent and treat certain types of serious (and sometimes life-threatening) arrhythmias called ventricular fibrillation and ventricular ...

Multiple placebo-controlled trials have demonstrated that intravenous vernakalant, a novel antiarrhythmic agent, effectively converts recent-onset atrial fibrillation in ∼50% of patients within 90 min ...